<DOC>
	<DOCNO>NCT00387634</DOCNO>
	<brief_summary>evaluate safety immunogenicity first TBE booster long-term immunogenicity 5 year first TBE booster</brief_summary>
	<brief_title>Safety Long-term Evaluation ( 5 Years ) First Booster Immunization With Novartis ' TBE Vaccine Adults Adolescents Adults</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>healthy subject complete study V48P7 acute illness day immunization general decrease resistance progressive neurological disorder history febrile afebrile convulsion major congenital defect serious chronic illness hypersensitivity study vaccine treatment immunosuppressant systemic corticosteroid , immunoglobulin , whole blood plasma derivates</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>tick bear encephalitis , TBE , adult</keyword>
</DOC>